• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Toll 样受体 3 L412F 多态性与特发性肺纤维化的疾病进展。

The Toll-like receptor 3 L412F polymorphism and disease progression in idiopathic pulmonary fibrosis.

机构信息

1 School of Medicine and Medical Science, College of Life Sciences, UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin, Ireland.

出版信息

Am J Respir Crit Care Med. 2013 Dec 15;188(12):1442-50. doi: 10.1164/rccm.201304-0760OC.

DOI:10.1164/rccm.201304-0760OC
PMID:24070541
Abstract

RATIONALE

Idiopathic pulmonary fibrosis (IPF) is a fatal progressive interstitial pneumonia. The innate immune system provides a crucial function in the recognition of tissue injury and infection. Toll-like receptor 3 (TLR3) is an innate immune system receptor. We investigated the role of a functional TLR3 single-nucleotide polymorphism in IPF.

OBJECTIVES

To characterize the effects of the TLR3 Leu412Phe polymorphism in primary pulmonary fibroblasts from patients with IPF and disease progression in two independent IPF patient cohorts. To investigate the role of TLR3 in a murine model of pulmonary fibrosis.

METHODS

TLR3-mediated cytokine, type 1 IFN, and fibroproliferative responses were examined in TLR3 wild-type (Leu/Leu), heterozygote (Leu/Phe), and homozygote (Phe/Phe) primary IPF pulmonary fibroblasts by ELISA, real-time polymerase chain reaction, and proliferation assays. A murine model of bleomycin-induced pulmonary fibrosis was used in TLR3 wild-type (tlr3(+/+)) and TLR3 knockout mice (tlr3(-/-)). A genotyping approach was used to investigate the role of the TLR3 L412F polymorphism in disease progression in IPF using survival analysis and longitudinal decline in FVC.

MEASUREMENTS AND MAIN RESULTS

Activation of TLR3 in primary lung fibroblasts from TLR3 L412F-variant patients with IPF resulted in defective cytokine, type I IFN, and fibroproliferative responses. We demonstrate increased collagen and profibrotic cytokines in TLR3 knockout mice (tlr3(-/-)) compared with wild-type mice (tlr3(+/+)). TLR3 L412F was also associated with a significantly greater risk of mortality and an accelerated decline in FVC in patients with IPF.

CONCLUSIONS

This study reveals the crucial role of defective TLR3 function in promoting progressive IPF.

摘要

背景

特发性肺纤维化(IPF)是一种致命的进行性间质性肺炎。先天免疫系统在识别组织损伤和感染方面起着至关重要的作用。Toll 样受体 3(TLR3)是先天免疫系统的受体。我们研究了功能性 TLR3 单核苷酸多态性在 IPF 中的作用。

目的

在特发性肺纤维化患者的原代肺成纤维细胞中,研究 TLR3 Leu412Phe 多态性在两个独立的特发性肺纤维化患者队列中的作用及疾病进展。研究 TLR3 在肺纤维化小鼠模型中的作用。

方法

通过 ELISA、实时聚合酶链反应和增殖试验,检测 TLR3 野生型(Leu/Leu)、杂合型(Leu/Phe)和纯合型(Phe/Phe)特发性肺纤维化患者原代肺成纤维细胞中 TLR3 介导的细胞因子、I 型干扰素和纤维增生反应。采用博莱霉素诱导的肺纤维化小鼠模型,研究 TLR3 野生型(tlr3(+/+))和 TLR3 敲除小鼠(tlr3(-/-))。采用基因分型方法,通过生存分析和 FVC 纵向下降,研究 TLR3 L412F 多态性在特发性肺纤维化疾病进展中的作用。

测量和主要结果

在 TLR3 L412F 变体的特发性肺纤维化患者的原代肺成纤维细胞中,TLR3 的激活导致细胞因子、I 型干扰素和纤维增生反应缺陷。与野生型小鼠(tlr3(+/+))相比,我们发现 TLR3 敲除小鼠(tlr3(-/-))中胶原和促纤维化细胞因子增加。TLR3 L412F 也与特发性肺纤维化患者的死亡率显著增加和 FVC 下降加速相关。

结论

本研究揭示了 TLR3 功能缺陷在促进进行性特发性肺纤维化中的关键作用。

相似文献

1
The Toll-like receptor 3 L412F polymorphism and disease progression in idiopathic pulmonary fibrosis.Toll 样受体 3 L412F 多态性与特发性肺纤维化的疾病进展。
Am J Respir Crit Care Med. 2013 Dec 15;188(12):1442-50. doi: 10.1164/rccm.201304-0760OC.
2
Candidate Role for Toll-like Receptor 3 L412F Polymorphism and Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.Toll样受体3 L412F多态性与特发性肺纤维化急性加重期感染的潜在关联
Am J Respir Crit Care Med. 2022 Mar 1;205(5):550-562. doi: 10.1164/rccm.202010-3880OC.
3
Toll-like receptor 3 L412F polymorphism promotes a persistent clinical phenotype in pulmonary sarcoidosis.Toll 样受体 3 L412F 多态性促进肺结节病的持续临床表型。
QJM. 2018 Apr 1;111(4):217-224. doi: 10.1093/qjmed/hcx243.
4
Association of TLR3 L412F Polymorphism with Cytomegalovirus Infection in Children.Toll样受体3基因L412F多态性与儿童巨细胞病毒感染的相关性
PLoS One. 2017 Jan 3;12(1):e0169420. doi: 10.1371/journal.pone.0169420. eCollection 2017.
5
CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis.成纤维细胞中 CD148 缺乏促进肺纤维化的发展。
Am J Respir Crit Care Med. 2021 Aug 1;204(3):312-325. doi: 10.1164/rccm.202008-3100OC.
6
Protein Tyrosine Phosphatase-N13 Promotes Myofibroblast Resistance to Apoptosis in Idiopathic Pulmonary Fibrosis.蛋白酪氨酸磷酸酶-N13 促进特发性肺纤维化中肌成纤维细胞抵抗细胞凋亡。
Am J Respir Crit Care Med. 2018 Oct 1;198(7):914-927. doi: 10.1164/rccm.201707-1497OC.
7
The biological significance of TLR3 variant, L412F, in conferring susceptibility to cutaneous candidiasis, CMV and autoimmunity.TLR3 变异体 L412F 赋予易感性的生物学意义,包括皮肤念珠菌病、CMV 和自身免疫。
Autoimmun Rev. 2012 Mar;11(5):341-7. doi: 10.1016/j.autrev.2011.10.007. Epub 2011 Oct 17.
8
Expression profiles of Toll-like receptors in non-small cell lung cancer and idiopathic pulmonary fibrosis.Toll 样受体在非小细胞肺癌及特发性肺纤维化中的表达谱。
Int J Oncol. 2012 May;40(5):1397-404. doi: 10.3892/ijo.2012.1374. Epub 2012 Feb 15.
9
Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.纤溶酶原激活物抑制剂-1抑制纤维化肺成纤维细胞中的促纤维化反应。
J Biol Chem. 2015 Apr 10;290(15):9428-41. doi: 10.1074/jbc.M114.601815. Epub 2015 Feb 3.
10
Targeting defective Toll-like receptor-3 function and idiopathic pulmonary fibrosis.针对Toll样受体-3功能缺陷与特发性肺纤维化
Expert Opin Ther Targets. 2015 Apr;19(4):507-14. doi: 10.1517/14728222.2014.988706. Epub 2014 Dec 22.

引用本文的文献

1
Epithelial damage and ageing: the perfect storm.上皮损伤与衰老:完美风暴。
Thorax. 2025 Aug 15;80(9):668-675. doi: 10.1136/thorax-2024-222060.
2
Fibrotic Pulmonary Sarcoidosis-From Pathogenesis to Management.纤维化型肺结节病——从发病机制到治疗
J Clin Med. 2025 Mar 30;14(7):2381. doi: 10.3390/jcm14072381.
3
Identification and Analysis of Key Immune- and Inflammation-Related Genes in Idiopathic Pulmonary Fibrosis.特发性肺纤维化中关键免疫和炎症相关基因的鉴定与分析
J Inflamm Res. 2025 Feb 11;18:1993-2009. doi: 10.2147/JIR.S489210. eCollection 2025.
4
Comprehensive analyses of immune activity in COVID-19-vaccinated idiopathic pulmonary fibrosis patients.对接种新冠疫苗的特发性肺纤维化患者免疫活性的综合分析。
Front Immunol. 2025 Jan 8;15:1436491. doi: 10.3389/fimmu.2024.1436491. eCollection 2024.
5
The immune mechanisms of acute exacerbations of idiopathic pulmonary fibrosis.特发性肺纤维化急性加重的免疫机制
Front Immunol. 2024 Dec 16;15:1450688. doi: 10.3389/fimmu.2024.1450688. eCollection 2024.
6
The Dawn of Precision Medicine in Fibrotic Interstitial Lung Disease.纤维化间质性肺疾病中精准医学的曙光。
Chest. 2025 Apr;167(4):1120-1132. doi: 10.1016/j.chest.2024.10.042. Epub 2024 Nov 8.
7
Lung fibrosis in sarcoidosis. Is there a place for antifibrotics?结节病中的肺纤维化。抗纤维化药物有立足之地吗?
Front Pharmacol. 2024 Aug 30;15:1445923. doi: 10.3389/fphar.2024.1445923. eCollection 2024.
8
Immune mechanisms in fibrotic interstitial lung disease.纤维化性间质性肺疾病中的免疫机制。
Cell. 2024 Jul 11;187(14):3506-3530. doi: 10.1016/j.cell.2024.05.015.
9
Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision Medicine.肺纤维化的遗传学和基因组学:描绘分子图谱,塑造精准医学。
Am J Respir Crit Care Med. 2024 Aug 15;210(4):401-423. doi: 10.1164/rccm.202401-0238SO.
10
Genetic Underpinnings of Pulmonary Fibrosis: An Overview.遗传性肺纤维化的基础:概述。
Cardiovasc Hematol Agents Med Chem. 2024;22(3):367-374. doi: 10.2174/0118715257261006231207113809.